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improves protein utilization efficiency while
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weaned pigs challenged with
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Abstract
Background: This experiment was conducted to test the hypothesis that vitamin E (Vit E) and acetylsalicylic acid
(ASA), a cyclooxygenase-2 (COX-2) inhibitor, will additively reduce the production of the immunosuppressive
molecule prostaglandin E2 (PGE2) and hence reduce inflammatory responses in weaner pigs experimentally infected
with an enterotoxigenic strain of E. coli.
Methods: The experiment was conducted in a research facility with 192 individually-housed male weaner pigs
(Landrace × Large White) weighing 6.6 ± 0.04 kg (mean ± SEM). The pigs were experimentally infected with an
enterotoxigenic strain of E. coli and were allocated to a 2 × 3 factorial design with the respective factors being
without and with 125 ppm ASA and three levels of Vit E supplementation (50, 100 or 200 IU/kg diet, dl-α-
tocopheryl acetate).
Results: Acetylsalicylic acid supplementation improved average daily gain (P < 0.05) and tended to improve feed:gain
ratio (P < 0.10) during the first 14 d after weaning. Acetylsalicylic acid supplementation also improved (P < 0.001) amino
acid utilization efficiency (as assessed by plasma urea level) and tended to decrease (P < 0.10) PGE2 production in the liver
without affecting small intestinal histology and tight junction protein mRNA expression in the jejunal epithelium. Vitamin
E supplementation greater than 100 IU/kg diet sustained both the plasma Vit E concentration (P < 0.001) and plasma
haptoglobin content (P < 0.001) after weaning. However, there was no additive effects of the combined supplementation
of ASA and Vit E on performance, intestinal barrier function and inflammatory responses of weaned pigs.
Conclusions: Although ASA and vitamin E improved amino acid utilization efficiency and reduced acute inflammatory
responses, ASA and vitamin E did not additively reduce production of PGE2 and inflammatory responses in weaner pigs
experimentally infected with an enterotoxigenic strain of E. coli.
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Background
Immune system activation alters nutrient partitioning
from deposition of body protein to production of im-
mune molecules [1] and provokes inflammatory re-
sponses such as fever, inhibition of appetite and
vomiting, which compromise the wellbeing and welfare
of pigs [2, 3]. These responses are caused by release of
pro-inflammatory cytokines and subsequent synthesis of
the immunosuppressive molecule prostaglandin E2
(PGE2), which is synthesized from arachidonic acid in
many tissues [4]. Therefore, reducing PGE2 production
by blocking conversion of arachidonic acid to PGE2,
which is facilitated by cyclooxygenase-2 (COX-2), will
reduce inflammatory responses and may have positive
effects on the health, welfare and performance of weaner
pigs [4]. Previously, acetylsalicylic acid (ASA, 125 ppm,
inhibiting COX-1 and COX-2) in diets for weaner pigs
was reported to improve performance and reduced diar-
rhea [5].
Another ingredient that has the ability to block PGE2
biosynthesis through prevention of lipid peroxidation is
vitamin E (Vit E) [6]. Weaning and E. coli infection are
known to reduce body Vit E reserves [7, 8], suggesting a
possible association between Vit E and inflammatory re-
sponses. This significant reduction in whole body Vit E
reserves in the first few wk after weaning is most likely
caused by an increased requirement for immune func-
tion during this critical period. Likoff et al. [9] demon-
strated a significant additive effect of Vit E (300 IU/kg
diet) and ASA (intraperitoneal injection of 50 mg/kg
body weight) supplementation on depression of PGE2
production and mortality in E. coli (LD50)-infected
broilers. However such a study to examine the additive
effects of ASA and Vit E supplementation has not been
conducted in weaner pigs using experimental infection
with an enterotoxigenic strain of E. coli. Therefore, this
experiment examined the hypothesis that supplementa-
tion of Vit E and ASA, a COX-2 inhibitor, will additively
reduce production of PGE2 and hence reduce the in-
flammatory responses in weaner pigs experimentally in-
fected with an enterotoxigenic strain of E. coli.
Methods
The experimental protocol used in this study was ap-
proved by the Department of Agriculture and Food
Western Australia Animal Ethics Committee (AEC 6-
12-19). Animals were handled according to the Austra-
lian Code of Practice for the Care and Use of Animals
for Scientific Purposes [10].
This experiment was conducted to examine the individ-
ual and additive effects of ASA and Vit E on growth per-
formance, aspects of gastrointestinal tract (GIT) structure
and function, inflammation responses measured as white
blood cell count and haptoglobin content, and PGE2
biosynthesis in the liver and spleen.
A total of 192 individually-housed male weaner pigs
(Landrace × Large White) weighing 6.6 ± 0.04 kg (mean ±
SEM) were allocated to a 2 × 3 factorial design, without
and with 125 ppm ASA (acetylsalicylic acid; Bayer
Australia, Pymble, NSW) and three levels of Vit E supple-
mentation (50, 100 or 200 IU dl-α-tocopheryl acetate/kg
diet; DSM, Wagga Wagga, Australia). This study mim-
icked the infection pressure of commercially housed pigs
at weaning using an experimental E. coli infection model
based on the assumption that E. coli infection with F4 fim-
bria after weaning remains a major cause of GIT dysfunc-
tion in some parts of the world [11–17]. There were 32
replications per treatment combination, with the experi-
ment conducted in two consecutive batches of 96 pigs. A
wheat, soybean meal and skim milk powder-based basal
diet was formulated to contain 15.3 MJ digestible energy
(DE)/kg (10.7 MJ net energy/kg) and 0.9 g standardized
ileal digestible lysine/MJ DE (Tables 1 and 2).
Pigs were fed experimental diets ad libitum and fresh
water was supplied through a bowl drinker. All pigs were
orally infected with an enterotoxigenic strain of E. coli
(ETEC; serogroup O149:K91:F4) on d 7, 8 and 9 after
weaning through oral drenching of 6, 10 and 10 mL of
ETEC solution containing 1.5 × 108 CFU/mL, respect-
ively. The E. coli solution was freshly prepared on the
day of dosing according to the method described in Heo
et al. [18]. On d 10 after weaning, eight selected pigs
(close to median weight) per treatment were euthanized
and the remaining 24 pigs were used for performance
measurement for a total duration of 21 d. Pigs were
weighed and feed intake was recorded weekly to calcu-
late performance indices. Expression of diarrhea and the
number of antibiotic treatments were recorded daily for
14 d after weaning. Blood samples were collected in
lithium-heparin tubes from all pigs on d 0, 7, 14 and 21
to determine the treatment effect on plasma vitamin E,
plasma urea, and haptoglobin over time. Additional
blood samples were collected in EDTA tubes from eu-
thanized pigs on d 10 to measure whole blood immune
cell counts.
Pigs were monitored daily for the presence of diarrhea.
Feces were scored daily depending on their consistency
using the following criteria: 1 = well-formed feces, firm
to cut; 2 = formed feces, soft to cut; 3 = feces falling out
of shape upon contact with surfaces and sloppy; 4 =
pasty and liquid diarrhea. Piglets were counted as having
diarrhea when the fecal consistency score was 4. To
comply with Animal Ethics Committee requirements,
pigs with diarrhea were treated immediately with an
intramuscular injection of Trisprim-480 (trimethropin
80 mg/mL, sulfadiazine, 400 mg/mL; Troy Laboratories,
Smithfield, Australia) or Moxylan (amoxicillin 150 mg/
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mL, Jurox Pty Ltd., Rutherford, Australia), and this was
repeated daily until the diarrhea ceased. The diarrhea
index was then expressed as the proportion of days with
diarrhea over 14 d after weaning. The number of thera-
peutic antibiotic treatments was recorded for the first 14
d. Fecal β-hemolytic E. coli shedding was measured on d
0, 7, 9, 11 and 13, by gently swabbing the rectum with a
cotton bud and overnight incubation of a fecal swab at
37 °C using 5 % horse blood agar plates [19].
Postmortem procedures
The eight median weight pigs per treatment were eutha-
nized on d 10 after weaning. Pigs were administered a
single intramuscular injection of 2 mg Xylazine/kg
(10 mg xylazil, Ilium Xylazil-100, Troy Laboratories Pty
Ltd, Smithfield, Australia) and 5 mg Zoletil/kg body
weight (10 mg tiletamine + 10 mg zolazepam, Zoletil
100, Virbac Pty Ltd, Peakhurst, Australia) to induce gen-
eral anesthesia, and then euthanized by intracardiac
injection of a lethal dose (2 mL/kg) of sodium pentobar-
bitone solution (Lethabarb; 325 g/mL pentobarbitone so-
dium, Virbac Australia Pty Ltd, Peakhurst, Australia).
The abdomen was then immediately opened from the
sternum to the pubis, and the GIT, liver and spleen were
removed. The small intestine was stripped free of its
mesentery and placed on a table into sections of equal
length. For measurement of villous height and crypt
depth, 3–4-cm segments of the small intestine were re-
moved at the jejunum (approximately midway along the
small intestine) and ileum (5 cm cranial to the ileo-cecal
junction), carefully washed with phosphate-buffered sa-
line (PBS) and preserved in 10 % phosphate-buffered
formalin solution for subsequent histological examin-
ation. Approximately 5 g of tissue from the right lobe of
the liver and anterior end of the spleen were collected,
washed with PBS, snap frozen in liquid nitrogen and
stored at −80 °C for subsequent analyses of PGE2 and
COX-2. Mucosal samples for tight junction protein gene
expression analysis were collected from approximately
20 cm-segments of the mid-jejunal region of the small
intestine. The jejunum was opened, washed with PBS,
collected mucosal scrapings using a sterile surgical







Full fat soya 5.0
Blood meal 1.24
Fishmeal 4.72












Crude protein, % 21.0
SID lysine, g/MJ DE 0.9
aAcetylsalyacyl acid and vitamin E were replaced with wheat on a weight basis
in the respective diets
bBJ Grower 1 (BioJohn Pty Ltd, Belmont, WA, Australia), provided the following
nutrients (per kg of air-dry diet): vitamins: A 7,000 IU, D3 1,400 IU, E 20 mg, K
1 mg, thiamine 1 mg, riboflavin 3 mg, pyridoxine 1.5 mg, cyanocobalamin
15 μg, calcium pantothenate 10.7 mg, folic acid 0.2 mg, niacin 12 mg, biotin
30 μg. Minerals: Co 0.2 mg (as cobalt sulfate), Cu 10 mg (as copper sulfate), I
0.5 mg (as potassium iodine), Fe 60 mg (as ferrous sulfate), Mn 40 mg
(as manganous oxide), Se 0.3 mg (as sodium selenite), Zn 100 mg (as ZnO)
Table 2 Analyzed amino acid and vitamin E contents of the
experimental diets (as-fed basis)
Acetylsalicylic acid 0 ppm 125 ppm
Added Vitamin E/kg diet 50 IU 100 IU 200 IU 50 IU 100 IU 200 IU
Amino acids, % as-fed
Indispensable amino acids
His 0.65 0.58 0.59 0.60 0.59 0.60
Ile 0.90 0.85 0.85 0.87 0.87 0.88
Leu 1.80 1.68 1.69 1.71 1.71 1.73
Lys 1.51 1.44 1.58 1.45 1.46 1.43
Met 0.72 0.66 0.67 0.68 0.71 0.67
Phe 1.14 1.04 1.06 1.08 1.08 1.09
Thr 1.19 1.06 1.09 1.04 1.06 1.11
Val 1.10 1.02 1.01 1.03 1.03 1.02
Dispensable amino acids
Ala 1.01 0.94 0.95 0.96 0.96 0.97
Arg 1.27 1.18 1.19 1.20 1.20 1.21
Asp 2.01 1.85 1.89 1.88 1.89 1.94
Cys 0.42 0.37 0.42 0.42 0.41 0.44
Glu 4.98 4.48 4.68 4.72 4.69 4.78
Gly 0.99 0.95 0.96 0.95 0.94 0.96
Pro 1.93 1.93 1.82 1.92 1.79 1.68
Ser 1.26 1.14 1.17 1.16 1.17 1.21
Tyr 0.83 0.78 0.80 0.79 0.80 0.80
α-tocopherol, mg/kg
as-fed
36 111 171 31 102 161
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blade, and stored in RNA stabilizer to prevent RNA deg-
radation (RNAlater, Qiagen, Chadstone, Australia). The
sample was stored at 4 °C for 24 h and then stored at
−20 °C until required for DNA extraction.
Chemical analysis
Amino acid (AA) contents in the experimental diets
were measured according to a method described by
Ranyer [20] with the modification of Barkholt and
Jensen [21]. Briefly, a 100 mg sample was hydrolysed
with 6 mol/L HCl, 0.5 % phenol and 0.05 % dithiodipro-
pionic acid to convert protein-bound AA to free AA.
The AA in the hydrolysate then underwent pre-column
derivatization with o-phthalaldehyde and fluorenyl-
methylchloroformate according to Hewlett Packard
Technical Note PN 12-5966-311E. The AA derivatives
were then separated and quantified by Reverse Phase
HPLC (Hewlett Packard 1100 HPLC with Diode Array
Detector). An Aglient Hypersill AA-ODS column
(200 mm × 2.1 mm, 5 microns) with pre-column was
used for all analyses. The column temperature employed
was 30 °C, detection was at 338 nm for primary AA (all
amino acids detected at 338 nm except proline which is
detected at 265 nm) and 262 nm for secondary AAs,
and the flow rate was 0.3 mL/min.
Vitamin E acetate (α-tocopherol) content in the feed
was measured using the method of McMurray et al.
[22]. Briefly, 1 g of feed was homogenised in 10 mL of
6 % pryrogallol by Ultraturrex. One mL of 60 % KOH in
water was added and the sealed tubes were heated at
70 °C for 30 min. After cooling, 5 mL of water and
20 mL of hexane was added. After extraction by vortex-
ing, 5 mL of the hexane layer was evaporated under ni-
trogen and made up in 0.5 mL of methanol (0.1 %
butylated hydroxytoluene). The chromatographic separ-
ation was performed with an Agilent HPLC system
(1100) using a Zorbax SB-C18 column (3 mm ×
150 mm, 3.5 μm, Agilent). Alpha-tocopherol was quanti-
fied using Fluorescence Detection (excitation 296 nm
and emission 330 nm).
Alpha tocopherol content in the plasma sample was
analysed using the method of McMurray and Blanch-
flower [23]. Briefly, 1 mL of plasma was deproteinized
with 1 mL of 1 % pryrogallol in ethanol and 5 mL of
hexane was added. After extraction by vortexing, 4 mL
of the hexane layer was evaporated under nitrogen and
made up in 0.5 mL of methanol (0.1 % butylated
hydroxytoluene). The chromatographic separation was
performed with an Agilent HPLC system (1100) using a
Zorbax SB-C18 column (3 mm × 150 mm, 3.5 μm) (Agi-
lent) with a methanol mobile phase. Alpha-tocopherol
was quantified using fluorescence detection (excitation
296 nm and emission 330 nm).
Haptoglobin content in the plasma sample was deter-
mined using a modified method of Makimura and
Suzuki [24]. Modifications were first, a higher concentra-
tion of sodium dihydrogen phosphate dihydrate
(30 mmol/L in reaction mix), and second, the use of a
commercial supply of hemoglobin (Sigma-Aldrich,
H2625) to produce the hemoglobin reagent (30 g/L in
normal saline). The method was adapted onto an Olym-
pus Au400 Automatic Analyzer (Olympus, Tokyo,
Japan).
Plasma urea content was measured using a urease
kinetic method with an automatic analyser (Randox
Daytona, Crumlin Co., Antrim, UK). Cyclooxygenase-2
(Novatein Biosciences, Cambridge, USA) and PGE2
(R&D Systems Inc., Minneapolis, USA) contents in the
liver and spleen samples were measured using commer-
cially available enzyme-linked immunosorbent assay
(ELISA) kits. Whole blood immune cell count was done
using an Automatic Hematology Analyzer (ADIVA 2120,
Bayer Healthcare, Siemens, Germany).
For mucosal histology examination, ring-shaped sec-
tions of the intestine from the jejunum and ileum were
excised, dehydrated, and embedded in paraffin wax, after
fixation for several days in 10 % phosphate-buffered
formalin. From each of these, six transverse sections
(4–6 μm) were cut, stained with hematoxylin and eosin,
and mounted on glass slides. The height of 10 well ori-
ented villi, their associated crypts, and thickness of the
muscular layer were measured with a light microscope
(OLYMPUS CX31, Tokyo, Japan) using a calibrated
eyepiece graticule.
Expressions of the mRNA encoding tight junction
proteins, Zonula Occludin-1 (ZO-1) and occludin, in the
jejunal mucosal scrapings were determined by a reverse
transcription-polymerase chain reaction (RT-PCR). For
RNA extraction, approximately 100 mg of mucosal
tissue scraping from the jejunum was placed into 1 mL
of TRIzol Reagent (Invitrogen, Mt Waverly, Australia).
This was then homogenized using a tissue homogenizer
for 45 s. Total RNA was extracted using the PureLink
RNA mini kit (Invitrogen, Mt Waverly, Australia) ac-
cording to the manufacturer’s instructions. Any possible
contamination of genomic DNA was eliminated using
PureLink DNase treatment (Invitrogen, Mt Waverly,
Australia). The RNA was reverse transcribed in a 50 μL
final volume using Superscript III (RT-SSIII) reverse
transcriptase (100 IU, Invitrogen, Waltham, USA) in 5 ×
RT buffer, with 2.5 ng/μL random primers, 10 mmol/L
each deoxynucleoside-triphosphate, 0.1 mol/L dithiotrei-
tol and 20 IU RNAsin. A heat start was applied for
2 min at 50 °C and then the RT-SSIII was added. Sam-
ples were incubated at 45 °C for 50 min and then 55 °C
for 30 min. The RT enzyme was heat inactivated (90 °C
for 5 min). Real-time PCR was performed using a
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Corbett Rotor-Gene 3000 Real Time Thermal Cycler
(Corbett Research, Sydney, Australia). The reactions
were performed in the presence of conventional forward
and reverse primers and SYBR Green (Invitrogen, Mt
Waverly, Australia). Primers for the target genes’ occlu-
din and ZO-1 used are presented in Table 3. Expression
of occludin and ZO-1 were normalized to an endogen-
ous control gene (Actin, β) to give a ΔCt value. This
accounted for variability in the initial starting amount of
cDNA. An aliquot of a previously run sample from a
standard curve with a known Ct value was also placed in
every run, to compare run-to-run variance and to deter-
mine the amount of the gene. Cycling conditions for
RT-PCR consisted of two holds of 50 °C for 2 min, 95 °C
for 10 min and then cycling for 40 cycles for 95 °C 15 s,
60 °C for 1 min and 60 °C for 60 s. Each sample was run
in triplicate. The Pfaffl [25] method was used to calcu-
late the relative expression of a target gene based on the
efficiency of the primers used and the Ct deviation of
the unknown gene versus a control, and expressed in
comparison to a reference gene.
Statistical analysis
Data were analyzed by two-way ANOVA using the pig as
the experimental unit. The main and interactive effects of
the supplemental Vit E and ASA were included as fixed
factors in the statistical model. As there was a significant
batch effect, it was included as a random factor in the stat-
istical model. Plasma urea, haptoglobin and Vit E contents
measured at the start of experiment (0 d) were used as co-
variates for statistical analysis on subsequent measurement
days. Fisher’s protected-LSD test was used to separate
means with significant treatment effects. Pearson’s correl-
ation analysis was conducted to detect relationships be-
tween dietary treatments, production of COX-2 and PGE2
in the liver, expression of tight junction protein genes in
the jejunal epithelium, and proportion of white blood cells.
Variability in the data was expressed as the SEM. A
probability level of P < 0.05 was considered to be statisti-
cally significant and P < 0.10 was considered as a trend. All
statistical analysis was conducted using Genstat 15th edi-
tion (VSN International Ltd, Hemel Hempstead, UK).
Results
Performance and indices of post-weaning colibacillosis
Supplementation of ASA alone improved (P < 0.05) aver-
age daily gain (ADG) and tended to improve (P < 0.10)
the gain:feed (G:F) ratio during the first 14 d after wean-
ing (Table 4). Significant interactions (P < 0.05) occurred
between ASA and Vit E for indices of post-weaning coli-
bacillosis, namely the diarrhea index and the number of
antibiotic treatments, such that supplementation of
200 IU Vit E/kg diet decreased the diarrhea index and
the number of antibiotic treatments but only with con-
current supplementation of 125 ppm ASA. Supplemen-
tation of ASA and 100 IU Vit E/kg diet independently
decreased (P < 0.05) the fecal β-hemolytic E. coli score
(Table 4).
Plasma Vit E, urea, haptoglobin levels, and blood cell
counts
Increasing the dietary Vit E content decreased (P < 0.001)
the extent of the reduction of plasma Vit E content after
weaning on all measured days (Fig. 1). Increasing Vit E
supplementation from 50 IU to 100 IU or 200 IU/kg diet
decreased plasma haptoglobin content after E. coli
infection (2.51, 2.26 and 1.99 mg/mL, respectively on d
10, P < 0.05; 2.36, 1.8 and 1.78 mg/L, respectively on d 14,
P < 0.001, Fig. 2), while ASA supplementation had no
effect (P > 0.05) on plasma haptoglobin content (2.31 and
2.20 mg/L on d 10; 2.05 and 1.91 mg/L on d 14 for with-
out and with ASA, respectively).
Acetylsalicylic acid supplementation decreased plasma
urea content after oral E. coli infection (5.0 vs.
4.3 mmol/L on d 10, P < 0.001; 5.1 vs. 4.7 mmol/L on d
14, P = 0.072) (Fig. 3), while Vit E supplementation had
Table 3 Primer sequences and conditions used for real-time PCR
Product Sequence Concentration
Primer Sequence size, bp GenBank ID nmol/La
Occludin
Forward 5′-GCAGCAGTGGTAACTTGGA-3′ 113 NM_001163647.2 200
Reverse 5′-GTCGTGTAGTCTGTCTCGTAATG-3′
ZO-1
Forward 5′-CGGCGAAGGTAATTCAGTGT-3′ 109 XM_003353439.2 200
Reverse 5′-CGGTTTGGTGGTCTGTAAGT-3′
Actin β
Forward 5′-GCCCGTCCATCGTCCACCG-3′ 127 XM_003357928 200
Reverse 5′-CAGGAGGCTGGCATGAGGTGTG-3′
aFinal concentration of primers used in real-time PCR
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no significant effect on plasma urea content (4.8, 4.7 and
4.5 mmol/L on d 10; 4.8, 4.8 and 5.0 mmol/L on d 14
for 50, 100 and 200 IU Vit E/kg, respectively). Increasing
the dietary Vit E content from 50 to 100 and 200 IU/kg
diet increased the number of platelets without ASA sup-
plementation (447, 488 and 569 × 109/L, respectively),
but decreased the number of platelets with ASA supple-
mentation (549, 598 and 435 × 109/L, respectively; inter-
action P = 0.058). Regardless of ASA supplementation,
Vit E supplementation at 100 IU increased (P < 0.05)
white blood cell numbers, and tended to increase (P =
0.078) the proportion of neutrophils while tending to
Table 4 The effects of acetylsalicylic acid (ASA) and vitamin E (Vit E) on performance and indices of post-weaning colibacillosis measured
for 21 d after weaning in E. coli-infected pigsa
ASA (A), ppm Vit E (E), IU P-value
0 125 SEM 50 100 200 SEM A E A × E
D 0 – 14
ADG, g/d 154 173 5.4 175 163 152 5.4 0.034 0.119 0.375
ADFI, g/d 180 182 5.2 190 181 171 5.2 0.998 0.090 0.503
G:F 0.87 0.94 0.022 0.93 0.90 0.88 0.022 0.087 0.587 0.175
D 0 – 21
ADG, g/d 234 245 5.6 250 240 230 5.6 0.218 0.183 0.614
ADFI, g/d 279 288 6.4 290 280 280 6.4 0.469 0.678 0.867
G:F 0.86 0.87 0.013 0.87 0.86 0.86 0.013 0.742 0.894 0.412
Diarrhoea index, %b 8.2 6.0 0.78 7.1 6.4 7.8 0.79 0.126 0.701 0.043
Antibioticc 1.8 1.7 0.16 1.8 1.8 1.7 0.17 0.724 0.910 0.023
E. coli scored 8.0 6.3 0.79 7.4 5.8 8.2 0.79 0.009 0.002 0.391
aAll pigs were experimentally infected with an enterotoxigenic strain of E. coli on 7, 8 and 9 d after weaning. The numbers of replications were 32 individual pigs
up to d 10 and 24 pigs from d 14 to 21
bDiarrhea index, %; mean percentage of days with diarrhea with respect to first 14 d after weaning. Significant interaction (P < 0.05) occurred between ASA and
Vit E for the diarrhoea index, such that supplementation of 200 IU Vit E/kg diet decreased diarrhoea index but only with concurrent supplementation of
125 ppm ASA
cMean number of antibiotic treatments. Significant interaction (P < 0.05) occurred between ASA and Vit E for the number of antibiotic treatments, such that
supplementation of 200 IU Vit E/kg diet decreased the number of antibiotic treatments but only with concurrent supplementation of 125 ppm ASA
dMean cumulative E. coli scores per diet in the 14 d after weaning
Fig. 1 Effect of dietary vitamin E levels on plasma vitamin E
contents after weaning. The numbers of replications were 32
individual pigs up to d 10 and were 24 pigs from d 14 to 21. All
pigs were experimentally infected with an enterotoxigenic strain of
E. coli on d 7 (after blood sampling), 8 and 9. ***P < 0.001
Fig. 2 Effect of dietary vitamin E levels on plasma haptoglobin
content after weaning. The numbers of replications were 32
individual pigs up to day 10 and were 24 pigs from day 14 to 21.
All pigs were experimentally infected with an enterotoxigenic
strain of E. coli on day 7 (after blood sampling), 8 and 9. *P < 0.05,
***P < 0.001
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decrease (P = 0.093) the proportion of lymphocytes
(Table 5).
Small intestinal structure, tight junction protein mRNA
expression in the jejunum, and PGE2 and COX-2 concen-
trations in the liver and spleen
There was a trend for supplementation of Vit E to in-
crease (P = 0.089) crypt depth in the ileum (202, 260,
223 μm for 50, 100 and 200 IU Vit E/kg diet, respect-
ively), otherwise ASA and Vit E supplementation had no
significant effects on small intestinal structure (results
not shown).
Relative expression of mRNA for tight junction pro-
teins, occludin and ZO-1, were measured in the jejunal
epithelium. There was large within-treatment variation
in mRNA expression for tight junction proteins that
limited detection of statistical differences between
treatments.
Acetylsalicylic acid tended to decrease PGE2 production
in the liver (24.5 vs. 28.2 ng/g wet tissue, P = 0.085, Fig. 4).
However, COX-2 contents in the liver were low and
showed no statistical differences between treatments.
Relationships between treatments and measured
variables
Acetylsalicylic acid intake was negatively correlated to
PGE2 content in the liver (P < 0.05). COX-2 concentra-
tion in the liver was negatively correlated to tight
junction protein gene expression in the jejunal epithe-
lium (occludin P < 0.05 and ZO-1 P < 0.001). Prostaglan-
din E2 concentration in the liver tended to positively
correlate with the proportion of lymphocytes and
neutrophils (P < 0.10) (Table 6).
Discussion
This study tested the hypothesis that Vit E supplementa-
tion and ASA, a COX-2 inhibitor, would additively re-
duce the production of PGE2 and hence reduce the
inflammatory responses in weaner pigs experimentally
infected with ETEC in a research facility.
Several on farm studies reported a strong negative re-
lationship between weaning and Vit E reserves in the
body [7, 26]. Prevention of lipid peroxidation via increas-
ing whole body Vit E reserve has been suggested to re-
duce the synthesis of eicosanoid mediators via negative
feedback mechanisms [4]. Therefore, one of the major
interests of this experiment was to examine whether
supplemental Vit E can increase Vit E body reserves
after weaning and inflammation challenge, and whether
the increased Vit E body reserve is associated with a re-
duction in PGE2 biosynthesis. Previous research showed
that plasma Vit E concentrations decrease markedly, to
less than 1.5 mg/L, when pigs were fed a diet containing
less than 100 IU Vit E/kg diet after weaning [7] or in-
fected with ETEC [8]. Considering the anti-oxidative
properties of Vit E, its requirement would be expected
to be greater when oxidative tissue damage is increased
in the immediate post-weaning period, due either to
Fig. 3 Effect of acetylsalicylic acid (125 ppm) on plasma urea
contents after weaning. The numbers of replications were 32
individual pigs up to d 10 and were 24 pigs from d 14 to 21. All
pigs were experimentally infected with an enterotoxigenic strain of
E. coli on d 7 (after blood sampling), 8 and 9. ***P < 0.001, †P < 0.10
Table 5 Effect of supplementation of acetylsalicylic acid (ASA) and vitamin E (Vit E) on selected blood cell numbers (n = 8) measured
on d 10 after weaning after experimental infection with an enterotoxigenic strain of E. coli
Items ASA (A), ppm Vit E (E), IU P=
0 125 SEM 50 100 200 SEM A E A × E
RBC, × 1012/L 6.4 6.5 0.07 6.5 6.5 6.3 0.07 0.826 0.374 0.902
CHCM, g/L 270 274 1.7 271 271 274 1.7 0.077 0.428 0.203
Platelet, × 109/L 501 527 24.5 498 543 502 24.7 0.575 0.675 0.058
WBC, × 109/L 17.6 19.2 1.00 16.7 22.3 16.2 0.93 0.407 0.017 0.938
Neutrophil, %a 48.9 49.7 1.63 46.8 54.2 46.9 1.57 0.769 0.078 0.576
Lymphocyte, %a 44.9 44.4 1.60 47.1 40.0 46.8 1.54 0.856 0.093 0.675
RBC red blood cell, CHCM mean red blood cell hemoglobin content, WBC white blood cell
aExpressed as a percentage of total white blood cell count
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stress and (or) (sub)clinical infection as a result of the
significant pathogen loads in commercial production
systems. Results in this study indicated that 200 IU Vit
E/kg diet was required to maintain plasma Vit E levels to
above 2 mg/L, which is in agreement with a previous re-
port [26]. Although supplementation of 200 IU Vit E/kg
diet was insufficient to maintain a plasma Vit E level of
3 mg/L, which has been suggested as the level required
for optimum immune function [27], supplementation
with 200 IU Vit E/kg diet maintained the plasma Vit E
level to greater than 2 mg/L even after ETEC infection,
and was also able to return the plasma Vit E level to
2.5 mg/L by d 21 after weaning. In this regard, Wilburn
et al. [26] reported that a plasma Vit E level of 3 mg/L
was not sustainable by supplementation of 300 IU Vit E
alone, but was able to be achieved by concurrent supple-
mentation of 300 IU Vit E/kg in the feed and 100 IU Vit
E/L in the drinking water.
One pathway through which acute immune system
activation depresses growth performance of pigs is stimu-
lation of the central nervous system by eicosanoid
mediators such as PGE2 [28, 29]. Recognition of patho-
gens and (or) stimulation of mast cells increases produc-
tion of eicosanoid mediators via pro-inflammatory
cytokines, which are causative for fever due to increased
metabolic rate and anorexia due to reduced appetite [2, 4].
Production of eicosanoid mediators in the cell and nuclear
membranes is initiated through the action of phospholip-
ase A2 or C, which respectively convert phospholipid and
diacylglycerol to arachidonic acid. Arachidonic acid is
then converted to PGE2 by COX-2 [28, 29]. Unlike
steroids and non-steroidal anti-inflammatory drugs
(NSAIDs), manipulation of dietary nutrients may not dir-
ectly inhibit the activities of phospholipase or COX-2.
However, it was anticipated that enhancing intestinal
barrier function and protection of cell damage through
supplementation of Vit E would reduce production of
eicosanoid mediators via negative feedback mechanisms
and therefore would improve the health and growth
efficiency of pigs [4, 30]. The results of the present study
showed that Vit E supplementation significantly decreased
the production of haptoglobin, an acute-phase protein,
Fig. 4 Effect of an acetylsalicylic acid (125 ppm) and dietary vitamin E levels on PGE2 concentration in the liver measured after 24 h of experimental
infection with an enterotoxigenic strain of E. coli in weaner pigs. The numbers of replications were 8 individual pigs. All pigs were experimentally infected
with an enterotoxigenic strain of E. coli on d 7, 8 and 9. Effect of acetylsalicylic acid P = 0.085; Vitamin E effect was not significant
Table 6 Pearson’s correlation coefficients between treatments and measured variables (Experiment 1)a
Acetylsalicylic acid intakeb Vitamin E intakea Liver COX-2 Liver PGE2 Occludin ZO-1 %Lymphocyte
Vitamin E intake −0.090
Liver COX-2 0.061 −0.096
Liver PGE2 −0.297* −0.195 −0.141
Occludin 0.037 −0.070 −0.357* 0.219
ZO-1 −0.059 0.062 −0.460*** −0.092 0.422**
%Lymphocytec 0.026 0.047 −0.158 0.263† 0.231 0.062
%Neutrophilc −0.012 −0.052 0.137 0.278† 0.210 −0.031 −0.989***
Significance †P < 0.10, *P < 0.05, **P < 0.01, ***P < 0.001
aCorrelation coefficient was derived from 48 observations (eight pigs per treatment × 6 treatments)
bAcetylsalicylic acid and vitamin E intakes were calculated by multiplying individual daily feed intake and dietary concentration of acetylsalicylic acid and
vitamin E
cPercentage of the total WBC count
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after ETEC infection and tended to increase the rate of
cell proliferation in the ileum (increased crypt depth).
Vitamin E supplementation (200 IU/kg) without ASA
supplementation increased tight junction protein mRNA
expression in the jejunal epithelium by 12–16 %. However
a very large within-treatment variation (CV 45 %)
hindered the generation of statistical significance. More-
over, Vit E supplementation did not influence COX-2 or
PGE2 concentration in the liver, although again there was
a numerical decrease (CV 27 %) in PGE2 concentration in
pigs fed all Vit E-supplemented diets. These findings
indicate that Vit E supplementation reduces the acute-
phase protein response mainly by preventing oxidative cell
damage under stress and ETEC infection, but has limited
effect on preventing the progression of the inflammatory
cascade via modulation of COX-2 activity and PGE2
production, which is inconsistent compared with findings
in broilers [9].
Acetylsalicylic acid is known to directly inhibit COX-1
and COX-2 via acetylating serine residues in the active
site of the enzymes, and hence eventually inhibits the
production of PGE2 [31]. Acetylsalicylic acid is also
known to interfere with blood clotting and wound
healing by reducing thromboxane A2 in the platelets and
inhibiting platelet aggregation [32]. Xu et al. [5] reported
that adding 125-ppm ASA in a starter diet for weaner
pigs decreased diarrhea and improved growth perform-
ance, whereas supplementation of 250 ppm ASA did not
further improve performance and health. The results of
the present study partly supported our hypothesis as
ASA in the diet at 125 ppm tended (P = 0.085) to
decrease PGE2 production in the liver without affecting
small intestinal histology and tight junction protein
mRNA expression in the jejunal epithelium. Pearson’s
correlation analysis also confirmed that individual pig
ASA intake was negatively correlated to PGE2 concen-
tration in the liver. However, ASA supplementation did
not significantly reduce COX-2 concentration in the
liver (only numerical reduction), and this may be attrib-
uted to the ability of ASA to primarily inhibit COX-1
rather than COX-2 activity [31].
Weaning per se significantly increased plasma urea
concentration from 3 mmol/L on the day of weaning to
4 mmol/L on d 7 after weaning, and experimental ETEC
infection on d 7–9 further increased plasma urea
concentration from 4 mmol/L to the level greater than
5 mmol/L on d 10 and 14 after weaning, representing
metabolic waste of amino acids for the immune response
[4]. However, pigs fed an ASA-supplemented diet main-
tained their plasma urea content to the pre-infection
level, especially immediately after ETEC infection. These
results most likely suggest that ASA supplementation
improved amino acid utilization efficiency by inhibiting
progression of inflammatory cascades through reducing
biosynthesis of the immunosuppressive molecule PGE2.
The finding that ASA supplementation improved ADG
and tended to improve G:F only in the first 14 d after
weaning may indicate that the metabolic waste of nutri-
ents due to immune system activation is more severe
during this period and then settled after 14 d, which is
in agreement with the pattern of plasma urea content as
demonstrated in the present study.
As the underlying mechanisms for Vit E and ASA on
infection responses of pigs are different, an additive
reduction of inflammatory response was hypothesized in
pigs fed a diet supplemented with both Vit E and ASA.
For example, it was reported that reducing bacterial load
by supplementation of an antibiotic (doxycycline) and
reducing PGE2 production by supplementation of ASA
additively decreased rectal temperature in finisher pigs
having respiratory disease [31]. Moreover, Likoff et al.
[9] demonstrated a strong additive effect of Vit E
(300 IU) and ASA (intraperitoneal injection of 50 mg/kg
body weight) on depression of PGE2 production and
mortality in E. coli (LD50)-infected broilers. However,
such an additive effect was not observed in the present
experiment except for interactions in the diarrhea index
and antibiotic treatments, where concurrent supplemen-
tation of ASA and Vit E was more effective than individ-
ual supplementation alone. Based on the results of
plasma and tissue measurements, therefore, it is likely
that ASA and Vit E supplementation independently
improved performance or inflammatory response of
weaned pigs by reducing inflammation-associated amino
acid waste through modulation of PGE2 biosynthesis, or
by reducing the severity of infection through an
eicosanoid-independent pathway such as oxidative tissue
damage due to its antioxidant property, respectively.
Conclusions
Individual and additive effects of ASA and Vit E supple-
mentation on performance, GIT structure and function
and aspects of immune function were investigated in
ETEC-challenged weaned pigs. Acetylsalicylic acid and
Vit E supplementation independently improved G:F and
inflammatory response, respectively, but no additive
effect was observed in performance, GIT structure and
function or immune function of weaned pigs. Based on
tissue measurements, it is suggested that ASA supple-
mentation may have improved performance of weaned
pigs by reducing inflammation-associated amino acid
waste through modulation of PGE2 biosynthesis, while
Vit E supplementation improved the inflammatory
response after ETEC infection by reducing the severity
of infection through an eicosanoid-independent pathway
such as oxidative tissue damage, due to its antioxidant
properties.
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